Skip to main content
Label
Case Study

Acute Migraine Study

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

CNS
Download the PDF

Challenge

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

‍

Solution

  • ObvioHealth used its drag-and-drop study designer to publish a test trial to the ObvioGo® mobile app, enabling walk-through from the participant perspective. This helped to identify where disengagement might occur and enabled mitigation strategies.
  • Participant training and comprehension quizzes ensure participants understand trial requirements and how to use the device.
  • ObvioHealth’s virtual site team is always available to provide participant support.'

‍

Study Design

  • Fully Virtual
  • Shipping Direct to Patients
  • eConsent
  • Virtual Site Team (COACH)
  • Comprehension Quizzes
  • ePRO
  • Remote Patient Monitoring
  • Remote Patient Training

‍

Results

The study is ongoing.

Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.

‍

Testimonial

"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."

Steve Schaefer

CEO, Mi-Helper, Inc.

Case Study

Acute Migraine Study

CNS
Download the PDF

45-Day

Recruitment Time

Study was recruited in 45 days versus the previous study’s 1.5 years.

Challenge

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

‍

Solution

  • ObvioHealth used its drag-and-drop study designer to publish a test trial to the ObvioGo® mobile app, enabling walk-through from the participant perspective. This helped to identify where disengagement might occur and enabled mitigation strategies.
  • Participant training and comprehension quizzes ensure participants understand trial requirements and how to use the device.
  • ObvioHealth’s virtual site team is always available to provide participant support.'

‍

Study Design

  • Fully Virtual
  • Shipping Direct to Patients
  • eConsent
  • Virtual Site Team (COACH)
  • Comprehension Quizzes
  • ePRO
  • Remote Patient Monitoring
  • Remote Patient Training

‍

Results

The study is ongoing.

Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.

‍

Testimonial

"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."

Steve Schaefer

CEO, Mi-Helper, Inc.

Case Study

Acute Migraine Study

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

CNS
Download the PDF

Challenge

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

‍

Solution

  • ObvioHealth used its drag-and-drop study designer to publish a test trial to the ObvioGo® mobile app, enabling walk-through from the participant perspective. This helped to identify where disengagement might occur and enabled mitigation strategies.
  • Participant training and comprehension quizzes ensure participants understand trial requirements and how to use the device.
  • ObvioHealth’s virtual site team is always available to provide participant support.'

‍

Study Design

  • Fully Virtual
  • Shipping Direct to Patients
  • eConsent
  • Virtual Site Team (COACH)
  • Comprehension Quizzes
  • ePRO
  • Remote Patient Monitoring
  • Remote Patient Training

‍

Results

The study is ongoing.

Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.

‍

Testimonial

"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."

Steve Schaefer

CEO, Mi-Helper, Inc.

Case Study

Acute Migraine Study

CNS
Download the PDF

Challenge

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

‍

Solution

  • ObvioHealth used its drag-and-drop study designer to publish a test trial to the ObvioGo® mobile app, enabling walk-through from the participant perspective. This helped to identify where disengagement might occur and enabled mitigation strategies.
  • Participant training and comprehension quizzes ensure participants understand trial requirements and how to use the device.
  • ObvioHealth’s virtual site team is always available to provide participant support.'

‍

Study Design

  • Fully Virtual
  • Shipping Direct to Patients
  • eConsent
  • Virtual Site Team (COACH)
  • Comprehension Quizzes
  • ePRO
  • Remote Patient Monitoring
  • Remote Patient Training

‍

Results

The study is ongoing.

Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.

‍

Testimonial

"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."

Steve Schaefer

CEO, Mi-Helper, Inc.

Case Study

Acute Migraine Study

CNS
Download the PDF

Challenge

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

‍

Solution

  • ObvioHealth used its drag-and-drop study designer to publish a test trial to the ObvioGo® mobile app, enabling walk-through from the participant perspective. This helped to identify where disengagement might occur and enabled mitigation strategies.
  • Participant training and comprehension quizzes ensure participants understand trial requirements and how to use the device.
  • ObvioHealth’s virtual site team is always available to provide participant support.'

‍

Study Design

  • Fully Virtual
  • Shipping Direct to Patients
  • eConsent
  • Virtual Site Team (COACH)
  • Comprehension Quizzes
  • ePRO
  • Remote Patient Monitoring
  • Remote Patient Training

‍

Results

The study is ongoing.

Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.

‍

Testimonial

"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."

Steve Schaefer

CEO, Mi-Helper, Inc.

Case Study

Acute Migraine Study

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

Download the PDF
CNS

Challenge

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

‍

Solution

  • ObvioHealth used its drag-and-drop study designer to publish a test trial to the ObvioGo® mobile app, enabling walk-through from the participant perspective. This helped to identify where disengagement might occur and enabled mitigation strategies.
  • Participant training and comprehension quizzes ensure participants understand trial requirements and how to use the device.
  • ObvioHealth’s virtual site team is always available to provide participant support.'

‍

Study Design

  • Fully Virtual
  • Shipping Direct to Patients
  • eConsent
  • Virtual Site Team (COACH)
  • Comprehension Quizzes
  • ePRO
  • Remote Patient Monitoring
  • Remote Patient Training

‍

Results

The study is ongoing.

Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.

‍

Testimonial

"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."

Steve Schaefer

CEO, Mi-Helper, Inc.

Back to Top
Case Study

Acute Migraine Study

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

CNS
Download the PDF

Challenge

Medical device company, Mi-Helper, Inc., needed to find participants with a specific type of migraine. This required a long run-in period and mitigation to reduce the risk of drop-off before participants reached active treatment. In addition, Mi-Helper needed to ensure participants used the at-home device properly.

‍

Solution

  • ObvioHealth used its drag-and-drop study designer to publish a test trial to the ObvioGo® mobile app, enabling walk-through from the participant perspective. This helped to identify where disengagement might occur and enabled mitigation strategies.
  • Participant training and comprehension quizzes ensure participants understand trial requirements and how to use the device.
  • ObvioHealth’s virtual site team is always available to provide participant support.'

‍

Study Design

  • Fully Virtual
  • Shipping Direct to Patients
  • eConsent
  • Virtual Site Team (COACH)
  • Comprehension Quizzes
  • ePRO
  • Remote Patient Monitoring
  • Remote Patient Training

‍

Results

The study is ongoing.

Thus far, training and comprehension quizzes have led to an engaged participant pool. Participant errors when using the device have been quickly addressed by the virtual site team.

‍

Testimonial

"ObvioHealth helped us figure out how to keep patients engaged without giving them more migraines. Incorporating the live chat feature and notifications into the project has eased the connection for the participants."

Steve Schaefer

CEO, Mi-Helper, Inc.

Discover More Case Studies

Discover More News

Discover More White Papers

Discover More Blogs

Discover More Playbooks

Discover More Webinars

Discover More Events

Infectious Disease

Norovirus Vaccine Study​

VaxArt needed solutions for evaluating the safety and immunogenicity of its orally administered norovirus vaccine. Of particular importance was incorporating a way to quickly detect severe reactogenicity symptoms during the first week following vaccine administration. ​

› Read More
CNS

Sub-Clinical Mood Disorders

A government agency is aiming to identify digital biomarkers of depressive and anxious feelings. The agency needed to capture both objective and subjective data for analysis.

› Read More